Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
Journal
-
- Annals of Oncology
-
Annals of Oncology 28 (10), 2581-2587, 2017-10
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1362825895247103232
-
- ISSN
- 09237534
-
- Data Source
-
- Crossref